Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-15
DOI
10.1038/s41598-017-18278-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of body mass index and survival in pediatric leukemia: a meta-analysis
- (2016) Etan Orgel et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes
- (2016) Jenny N. Poynter et al. Cancer Epidemiology
- From obesity to cancer: a review on proposed mechanisms
- (2016) Zoya Tahergorabi et al. CELL BIOCHEMISTRY AND FUNCTION
- Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche
- (2016) Haobin Ye et al. Cell Stem Cell
- Epigenome-wide association study of body mass index and the adverse outcomes of adiposity
- (2016) Simone Wahl et al. NATURE
- Marrow Adipose Tissue: Trimming the Fat
- (2016) Erica L. Scheller et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy
- (2015) Suzanne Tavitian et al. AMERICAN JOURNAL OF HEMATOLOGY
- Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials
- (2015) Jorge J. Castillo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy
- (2015) Laura Finn et al. Cancer Epidemiology
- Long-term follow-up of homoharringtonine plus all-trans retinoic acid-based induction and consolidation therapy in newly diagnosed acute promyelocytic leukemia
- (2015) Ying Wang et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Chemotherapy dose in obese AML patients: To cap or not to cap?
- (2015) Mary-Elizabeth M. Percival et al. LEUKEMIA RESEARCH
- Acute promyelocytic leukemia: where did we start, where are we now and the future
- (2015) C C Coombs et al. Blood Cancer Journal
- Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults
- (2014) Krishnan Bhaskaran et al. LANCET
- Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia
- (2014) Emmanuelle Kempf et al. LEUKEMIA RESEARCH
- Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight
- (2013) Candice M. Wenzell et al. AMERICAN JOURNAL OF HEMATOLOGY
- Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia
- (2013) Andrew M. Brunner et al. AMERICAN JOURNAL OF HEMATOLOGY
- Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study
- (2013) F Murphy et al. BRITISH JOURNAL OF CANCER
- Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC)
- (2013) Fatemeh Saberi Hosnijeh et al. CANCER CAUSES & CONTROL
- Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia
- (2013) Houry Leblebjian et al. LEUKEMIA RESEARCH
- Adipocytes: Impact on tumor growth and potential sites for therapeutic intervention
- (2013) Simona Hefetz-Sela et al. PHARMACOLOGY & THERAPEUTICS
- Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can)
- (2012) Gabriele Nagel et al. ANNALS OF HEMATOLOGY
- Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia
- (2012) B. C. Medeiros et al. HAEMATOLOGICA
- Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia
- (2012) Andrew Lin et al. LEUKEMIA & LYMPHOMA
- Obesity but not overweight increases the incidence and mortality of leukemia in adults: A meta-analysis of prospective cohort studies
- (2012) Jorge J. Castillo et al. LEUKEMIA RESEARCH
- Is obesity a prognostic factor for acute myeloid leukemia outcome?
- (2011) Hun Ju Lee et al. ANNALS OF HEMATOLOGY
- Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols
- (2011) M. Breccia et al. BLOOD
- TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
- (2011) Ramzi Jeddi et al. Mediterranean Journal of Hematology and Infectious Diseases
- Treatment of acute promyelocytic leukemia with PETHEMA LPA 99 protocol: a Tunisian single center experience
- (2010) Ramzi Jeddi et al. Hematology
- Obesity and the Risk for a Hematological Malignancy: Leukemia, Lymphoma, or Myeloma
- (2010) M. A. Lichtman ONCOLOGIST
- High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia
- (2009) Ramzi Jeddi et al. LEUKEMIA RESEARCH
- A hospital-based case-control study of acute myeloid leukemia in Shanghai: Analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification
- (2009) Otto Wong et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Overweight, obesity and risk of haematological malignancies: A cohort study of Swedish and Finnish twins
- (2008) Karin C. Söderberg et al. EUROPEAN JOURNAL OF CANCER
- Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia
- (2008) Ramzi Jeddi et al. Hematology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started